Internal Server Error

Cellacure - About the company

Cellacure is a funded company based in Atlanta (United States). It operates as an Operator of a drug research and development company focused on immunotherapy. Cellacure has raised an undisclosed amount in funding. The company has 3440 active competitors, including 1127 funded and 790 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, BeiGene and Kite Pharma.

Company Details

Operator of a drug research and development company focused on immunotherapy. The company focuses on global product development and commercialization to address unmet clinical needs. These needs are caused by cancer, infectious diseases, and chronic inflammatory diseases. The company aims to provide cell-based cancer cures for solid tumors and hematological malignancies.
Key Metrics
Location
Atlanta, United States
Stage
Funding Raised
Ranked
3996th among 4065 competitors
Similar Companies
Sign up to download Cellacure's company profile

Cellacure's funding and investors

Cellacure has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Jan 07, 2025 for $*****. 1 investor participated in its latest round. Cellacure has 1 institutional investor.

Here is the list of recent funding rounds of Cellacure:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jan 07, 2025
4728214
Grant (prize money)
6555537
7396760
4724832
4533974
lockAccess funding benchmarks and valuations. Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Cellacure's Competitors and alternates

Top competitors of Cellacure include Jazz Pharmaceuticals, BeiGene and Kite Pharma. Here is the list of Top 10 competitors of Cellacure, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Jazz Pharmaceuticals
Jazz Pharmaceuticals
2003, Dublin (Ireland), Public
Developer of novel biopharmaceutical medicines for unmet medical needs
$265M
82/100
2nd
Logo for BeiGene
BeiGene
2010, Cambridge (United States), Public
Developer of targeted and immune-oncology drugs against cancer
$172M
77/100
3rd
Logo for Kite Pharma
Kite Pharma
2009, Los Angeles (United States), Acquired
Developer of cancer immunotherapy products using genetic engineering
$97.7M
76/100
4th
Logo for Attovia
Attovia
2023, Fremont (United States), Public
Developer of antibody-based therapeutics for immune-mediated diseases and oncology
$255M
72/100
5th
Logo for Tango Therapeutics
Tango Therapeutics
2017, Cambridge (United States), Public
Developer of drugs for the treatment of cancer
$165M
72/100
6th
Logo for Elicio
Elicio
2012, Cambridge (United States), Public
Developer of vaccines for treating cancer
$47.4M
72/100
7th
Logo for Immuneel
Immuneel
2018, Bengaluru (India), Series B
Developer of T-cell therapies for the treatment of cancer
$49.8M
71/100
8th
Logo for BioNTech
BioNTech
2008, Mainz (Germany), Public
Developer of immunotherapeutics for the treatment of cancer and other diseases
$861M
71/100
9th
Logo for Erasca
Erasca
2018, San Diego (United States), Public
Developer of small molecule based therapeutics for cancer
$300M
71/100
10th
Logo for Strand Therapeutics
Strand Therapeutics
2017, Cambridge (United States), Series B
Provider of platform to deliver mRNA therapeutics for multi functional treatments
$256M
71/100
3996th
Logo for Cellacure
Cellacure
Atlanta (United States), Funding Raised
Operator of a drug research and development company focused on immunotherapy
-
15/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Cellacure's competitors? Click here to see the top ones

Cellacure's Investments and acquisitions

Cellacure has made no investments or acquisitions yet.

Reports related to Cellacure

Here is the latest report on Cellacure's sector:

FAQs about Cellacure

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford